Prescription painkiller overdoses has risen 400% in women, says the US CDC
Women in the USA are dying from prescription painkiller overdoses at rates never seen before, according to analysis from the US Centers for Disease Control and Prevention (CDC).
CDC’s Vital Signs report shows that prescription painkiller overdoses killed nearly 48,000 women between 1999 and 2010. Painkillers referred to in its study are opioid or narcotic pain relievers, including Vicodin (hydrocodone) from Abbott Laboratories (NYSE: ABT), OxyContin (oxycodone), a product of privately-held Purdue Pharma, and Opana (oxymorphone) from Endo Health Solutions (Nasdaq: ENDP), as well as methadone.
The CDC report said that while men are more likely to die of a prescription painkiller overdose, the percentage increase in deaths since 1999 was 400% in women compared to 265% in men.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Generics
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze